Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
21.87 USD | +2.87% | +9.30% | -24.35% |
Jul. 01 | Fulgent Genetics, Inc.(NasdaqGM:FLGT) dropped from Russell 2000 Value-Defensive Index | CI |
Jul. 01 | Fulgent Genetics, Inc.(NasdaqGM:FLGT) dropped from Russell 2000 Defensive Index | CI |
Business Summary
Number of employees: 1,184
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Laboratory Services
100.0
%
| - | - | 289 | 100.0 % | - |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
93.0
%
| 603 | 97.4 % | 269 | 93.0 % | -55.40% |
Foreign
7.0
%
| 16 | 2.6 % | 20 | 7.0 % | +27.91% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Ming Hsieh
CEO | Chief Executive Officer | 68 | 16-05-12 |
James Xie
FOU | Founder | 58 | 16-05-12 |
Paul Kim
DFI | Director of Finance/CFO | 56 | 15-12-31 |
Doreen Ng
CMP | Compliance Officer | - | 20-09-30 |
Lawrence Weiss
CTO | Chief Tech/Sci/R&D Officer | 67 | 21-05-05 |
Harry Gao
CTO | Chief Tech/Sci/R&D Officer | 57 | 12-01-31 |
Jakub Sram
SAM | Sales & Marketing | - | 13-12-31 |
Ellen Tsui
HRO | Human Resources Officer | - | 18-03-31 |
Natalie Prescott
LAW | General Counsel | - | 22-05-02 |
Mary Jane Abalos
PRN | Corporate Officer/Principal | 50 | 20-06-30 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Ming Hsieh
CEO | Chief Executive Officer | 68 | 16-05-12 |
Linda Marsh
BRD | Director/Board Member | 74 | 19-07-31 |
Regina Groves
BRD | Director/Board Member | 66 | 23-01-02 |
Michael Nohaile
BRD | Director/Board Member | 55 | 22-07-31 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 32,698,288 | 20,194,941 ( 61.76 %) | 2,774,000 ( 8.484 %) | 61.76 % |
Company contact information
Fulgent Genetics, Inc.
4399 Santa Anita Avenue
91731, El Monte
+626 350 0537
http://www.fulgentgenetics.comSector
Sales per Business
Sales per region
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-24.35% | 636M | |
-18.17% | 8.55B | |
+87.40% | 4.63B | |
+16.31% | 2.98B | |
-3.15% | 2.65B | |
-2.10% | 1.89B | |
-53.27% | 1.81B | |
-12.97% | 1.56B | |
+21.59% | 1.27B | |
-47.96% | 1.07B |
- Stock Market
- Equities
- FLGT Stock
- Company Fulgent Genetics, Inc.